Cochlear Implantation in Children Under 9 Months of Age: Safety and Efficacy

Abstract

Objective To assess the safety of cochlear implants (CIs) in children under 9 months of age to better understand expected postoperative complication rates, and to provide a preliminary look at efficacy. Study Design Single-center retrospective review. Setting Tertiary referral center. Patients Children 5 to 8 months of age who received a CI between 2011 and 2021. Interventions Therapeutic—CI. Main Outcome Measures The primary outcome was 6-month postoperative complication rate. Secondary outcomes included length of stay, device explantation/reimplantation, rehabilitation supports, and hearing and language outcomes. Complications of children implanted under than 9 months of age was compared with a cohort of children implanted 9 to 18 months of age between the years 2011 and 2016 using a chi-squared test (p < 0.05). Results One hundred six children under 9 months of age were implanted (204 CIs) at a mean age of 6.6 months (range: 5–8). Postoperative complications occurred in 28 patients (26%) and were often minor. There were no mortalities. There was no statistically significant difference in complications, including reimplantation rates, between patients implanted under 9 months of age and those implanted 9 to 18 months of age. Speech discrimination outcomes were excellent, and mean spoken language outcomes were near normative for typically developing children. Conclusions Cochlear implantation can be a safe and effective treatment option for children 5 to 8 months of age. Early hearing screening and referral for infants to receive appropriate intervention will continue to play a critical role in optimizing speech and language outcomes.